orbitopathy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

67 results for “orbitopathy”

Trials

View all 62 →

Sirolimus in Graves' Orbitopathy

30 participants · First posted Apr 25, 2022

Graves' Orbitopathy and Hypercholesterolemia

250 participants · First posted Mar 29, 2016

Disappearance of Graves' Orbitopathy

99 participants · First posted Apr 6, 2017

News

PolyActiva's PA5108 Glaucoma Implant Demonstrates Promising IOP Reduction in Phase 2 Trial

TEPEZZA Sales Surge as Thyroid Eye Disease Treatment Market Expands to $2.3 Billion

argenx Discontinues Phase 3 UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease Following Futility Analysis

Page 1 of 7